GlassScriptPhysician profile
Benjamin C Jessie
NPI 1700062825
$2,101.46
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $101 · 2021: $76.83 · 2022: $678 · 2023: $463 · 2024: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $323.75 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $261.75 | 2019-2023 | Bard Urinary Drainage Bag |
| Rochester Medical Corporation | $180.28 | 2022 | |
| Boston Scientific Corporation | $161.60 | 2019-2024 | Ams 700, Rezum Generator |
| Accord Healthcare, INC. | $159.33 | 2022-2023 | |
| Blue Earth Diagnostics | $129.28 | 2019-2023 | |
| Pfizer INC. | $95.25 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $70.96 | 2019-2023 | Xiaflex |
| Myriad Genetic Laboratories, INC. | $66.13 | 2023-2024 | Prolaris, Myrisk |
| Teleflex LLC | $45.25 | 2022-2023 | Urolift |
| Convatec INC. | $44.73 | 2022 | |
| Urovant Sciences INC | $44.38 | 2022 | |
| Sumitomo Pharma America, INC. | $37.21 | 2023-2024 | Gemtesa |
| Dendreon Pharmaceuticals LLC | $37.13 | 2019 | |
| Medtronic, INC. | $31.67 | 2022-2023 | Interstim |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $31.25 | 2019-2022 | |
| Mission Pharmacal Company | $29.74 | 2019 | |
| Tolmar, INC. | $29.63 | 2023 | |
| Ferring Pharmaceuticals INC. | $29.09 | 2019 | |
| Laborie Medical Technologies Corp. | $28.35 | 2021-2022 | |
| Olympus America INC. | $28.33 | 2022 | |
| Abbvie INC. | $26.09 | 2023 | |
| Ethicon US, LLC | $24.74 | 2019 | |
| Becton, Dickinson and Company | $23.79 | 2022 | |
| Innovation Technologies INC | $18.76 | 2024 | Irrisept |
| 180 Medical, INC. | $18.01 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $17.92 | 2022 | |
| Ambu INC. | $17.52 | 2024 | |
| Janssen Biotech, INC. | $17.33 | 2019 | |
| Varian Medical Systems, INC. | $15.55 | 2020 | |
| Antares Pharma, INC. | $14.92 | 2019 | |
| Coloplast Corp | $14.31 | 2022 | |
| Verity Pharmaceuticals INC. | $14.02 | 2023 | Trelstar |
| Conmed Corporation | $13.41 | 2023 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Jessie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.